Literature DB >> 1331143

Restriction endonuclease patterns of adenovirus type 12 and 18.

A Thörner1, M E Johansson, J C Hierholzer.   

Abstract

Restriction endonuclease analysis using 10 restriction enzymes was performed on six and three wild isolates of adenovirus (Ad) type 12 and 18, respectively. Among the Ad12 strains, five DNA variants could be identified. The degree of pairwise comigration of restriction fragments suggests a high degree of genomic diversity within Ad12. The wild isolates of Ad18, on the other hand, displayed a low degree of genetic variability and comprised one DNA variant closely related to the prototype strain. The BglII, BstEII, and HindIII restriction endonuclease patterns of Ad18 were inconsistent with those originally presented. Identical RE-patterns among Ad18 prototype strains (DC) obtained from four different sources, including directly from the American Type Culture Collection, verify that the genuine Ad18 prototype was used in the present study. Using the revised restriction patterns of BglII, BstEII, and HindIII, a proper identification of Ad18 will be facilitated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331143     DOI: 10.1016/0166-0934(92)90129-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

1.  Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis.

Authors:  J Sprengel; B Schmitz; D Heuss-Neitzel; C Zock; W Doerfler
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

2.  Adenoviruses isolated in the Stockholm area during 1987-1992: restriction endonuclease analysis and molecular epidemiology.

Authors:  M E Johansson; M A Andersson; P A Thörner
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Characterization of two divergent adenovirus 31 strains.

Authors:  P A Thörner; M Ahrel-Andersson; J C Hierholzer; M E Johansson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.